Protein Synthesis in Cancer Initiation, Progression, Metastasis, and Dormancy

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".

Deadline for manuscript submissions: closed (25 January 2025) | Viewed by 1565

Special Issue Editor


E-Mail Website
Guest Editor
1. Laboratory of mRNA & Cancer, Unit of Biomedical Research on Cancer, National Institute of Cancer (Instituto Nacional de Cancerología, INCan), Mexico City 14080, Mexico
2. School of Medicine and Health Sciences, Tecnológico de Monterrey, Mexico City 14380, Mexico
Interests: developmental biology; molecular biology; cancer

Special Issue Information

Dear Colleagues,

Cancer is one of the most prevalent diseases worldwide. Despite the advances in the understanding of the molecular processes driving the onset and progression of this disease, cancer still remains a significant cause of morbidity and mortality, particular in low-income countries. Translation, i.e., the decoding of a genetic message carried by a messenger (m)RNA into a polypeptide by the ribosome and translation factors, plays a crucial role in the composition of the proteome in all forms of life and diseases. Dysregulation of the translation process has emerged as a crucial cause of tumorigenesis. Indeed, various translation factors include oncogenes, while others are overexpressed in tumors, and some components of the translational machinery are mutated across different types of neoplastic phenotypes. Moreover, malfunctioning of the signal transduction cascades controlling translation are also involved in the onset and progression of cancer. Thus, the targeting of translation initiation is investigated as part of the global applications in some emerging therapies used to treat carcinogenesis.

We dedicate this Special Issue to discuss the state of the art of key aspects of protein synthesis in cancer initiation, progression, metastasis, and dormancy. This includes the misexpression of translation factors, dysregulation of the major signaling cascades regulating translation, and therapeutic strategies based on pharmacological compounds targeting translation.

Dr. Greco Hernández
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer
  • translational control
  • protein synthesis
  • mTOR pathway
  • cancer therapeutics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

28 pages, 2789 KiB  
Review
The Bright Future of mRNA as a Therapeutic Molecule
by Dora Emma Vélez, Blanca Licia Torres and Greco Hernández
Genes 2025, 16(4), 376; https://doi.org/10.3390/genes16040376 - 26 Mar 2025
Cited by 1 | Viewed by 1301
Abstract
The rapid success of messenger (m) RNA vaccines against COVID-19 has pushed the mRNA to the forefront of drug research. The promise of mRNA-based therapeutics and vaccines in other areas is not new but is now emerging stronger. We review basic concepts, key [...] Read more.
The rapid success of messenger (m) RNA vaccines against COVID-19 has pushed the mRNA to the forefront of drug research. The promise of mRNA-based therapeutics and vaccines in other areas is not new but is now emerging stronger. We review basic concepts, key historical aspects, and recent research on mRNA as a therapeutic molecule to fight infectious diseases and cancer. We also show a current patent perspective of this field. Altogether, we describe that the technology of mRNA as a therapeutic molecule is a rapidly moving field aiming for a bright future. Full article
Show Figures

Graphical abstract

Back to TopTop